Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study
CONCLUSIONS: Germline BRCA mutations positively affect chemosensitivity in EOC, but whether differences in toxicities among BRCA-associated and BRCA wild type tumors existed was previously not reported. In this population with newly diagnosed ovarian cancer no differences in reported toxicity between the two groups was observed.PMID:33610319 | DOI:10.1016/j.ygyno.2021.01.037
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Jessica Gillen Austin Miller Katherine M Bell-McGuinn Russell J Schilder Joan L Walker Cara A Mathews Linda R Duska Saketh R Guntupalli Roisin O'Cearbhaill John Hays Andrea R Hagemann Heidi J Gray Sarah W Gordon Deborah K Armstrong Alice Chen Paula M Frac Source Type: research
More News: Anemia | Avastin | Brain | Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Neurology | Ovarian Cancer | Ovaries | Pain | Statistics | Study | Toxicology | Women